A landmark paper published in The Lancet Neurology journal by leaders of the Parkinson's Progression Markers Initiative (PPMI), the gold-standard Parkinson's biomarker study sponsored by The...
M2GEN, an oncology bioinformatics company with the most advanced lifetime-consented clinicogenomic data to accelerate medical product discovery, announced it is rebranding, changing the company's...
Agena Bioscience and nRichDX have advanced their existing technical collaboration to a commercial partnership that co-promotes their products to researchers developing liquid biopsy applications...
Otsuka Pharmaceutical Development & Commercialization, Inc, and Lundbeck Pharmaceuticals LLC announce the Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Peripheral and...
Dalrada Financial Corporation, a problem-solving innovator that takes on complex, multi-disciplinary challenges in clean energy, precision manufacturing, and technology, announced that global business executive,...
